Thus, we decided to evaluate the expression of TNFR1 and TNFR2 on these T cell subpopulations in RA patients before and after anti-TNF-α therapy with adalimumab and compare it with that of healthy controls. This evidence concerns the gene TNF and rheumatoid arthritis.